Search Within

Jedd D Wolchok

  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (21)
Groups
  1. Department of Medicine (49)
  2. GSK Faculty (49)
  3. MSK Grad Students (49)
  4. Melanoma and Immunotherapeutics Service (49)
  5. Solid Tumor Oncology Division (49)
  6. Sloan Kettering Institute Postdocs (46)

More Groups

People
  1. Taha Merghoub (42)
  2. Sadna Budhu (23)
  3. Roberta Zappasodi (17)
  4. Levi Mark Mangarin (14)
  5. Hong Zhong (13)
  6. Sara Schad (13)

More People

Years
  1. 2023 (2)
  2. 2022 (11)
  3. 2021 (9)
  4. 2020 (11)
  5. 2019 (7)
  6. 2018 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (11)
  2. Cancer Research (9)
  3. Journal of Clinical Oncology (4)
  4. Nature (4)
  5. Journal of Immunology (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. Biomed Central Ltd (11)
  3. Nature Publishing Group (6)
  4. Cell Press (5)
  5. American Society of Clinical Oncology (4)
  6. The American Association of Immunologists, Inc (3)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Development of optimized car T cells for therapy of glioblastoma
    Meeting Abstract

    Khan, J.; Cai, W.; Yang, Y.; Dong, L.; Hopland, K.; Yu, K. K. H.; Freeman, R.; Purdon, T.; Tabar, V.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • MCT4 blockade reverses lactate-mediated immunosuppression in LKB1-deficient NSCLC
    Meeting Abstract

    Qian, Y.; Guijarro, I.; Galan-Cobo, A.; Dang, M.; Poteete, A.; Zhang, F.; Wang, Q.; Wang, J.; Parra, E.; Skoulidis, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save